Case of drug-induced interstitial lung disease secondary to adalimumab
© BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ..
In conjunction with BMJ Case Reports, DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:56 |
|---|---|
| Enthalten in: |
Drug and therapeutics bulletin - 56(2018), 12 vom: 23. Dez., Seite 150-153 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Alaee, Seema [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Adalimumab |
|---|
| Anmerkungen: |
Date Completed 12.09.2019 Date Revised 12.09.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/dtb.2018.12.224375rep |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM291020992 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM291020992 | ||
| 003 | DE-627 | ||
| 005 | 20231225070002.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/dtb.2018.12.224375rep |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0970.xml |
| 035 | |a (DE-627)NLM291020992 | ||
| 035 | |a (NLM)30470710 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Alaee, Seema |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Case of drug-induced interstitial lung disease secondary to adalimumab |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 12.09.2019 | ||
| 500 | |a Date Revised 12.09.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © BMJ Publishing Group Limited 2018. No commercial re-use. See rights and permissions. Published by BMJ. | ||
| 520 | |a In conjunction with BMJ Case Reports, DTB will feature occasional drug-related cases that are likely to be of interest to readers. These will include cases that involve recently marketed drugs for which there is limited knowledge of adverse effects and cases that highlight unusual reactions to drugs that have been marketed for several years | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Journal Article | |
| 650 | 7 | |a Anti-Inflammatory Agents |2 NLM | |
| 650 | 7 | |a Adalimumab |2 NLM | |
| 650 | 7 | |a FYS6T7F842 |2 NLM | |
| 700 | 1 | |a Jones, Quentin |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Drug and therapeutics bulletin |d 1965 |g 56(2018), 12 vom: 23. Dez., Seite 150-153 |w (DE-627)NLM000016047 |x 1755-5248 |7 nnns |
| 773 | 1 | 8 | |g volume:56 |g year:2018 |g number:12 |g day:23 |g month:12 |g pages:150-153 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/dtb.2018.12.224375rep |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 56 |j 2018 |e 12 |b 23 |c 12 |h 150-153 | ||